No document available.
Keywords :
Adult; Antiviral Agents/therapeutic use; Bone Marrow Transplantation/methods; Cytomegalovirus Infections/complications/drug therapy; Female; Ganciclovir/therapeutic use; Graft Rejection; Graft vs Host Disease/etiology; Hematopoiesis; Humans; Leukemia, Myelomonocytic, Chronic/complications/therapy; Male; Myelodysplastic Syndromes/blood; Recurrence
Abstract :
[en] We report a patient with poor-prognosis myelodysplastic syndrome (MDS) after successful treatment of lymphoma, who was given an allogeneic BMT, engrafted and achieved complete remission, but later had a relapse of his MDS with complete disappearance of donor haemopoiesis. After two episodes of CMV pneumonia and continued prophylactic use of ganciclovir thereafter, he experienced a spontaneous complete disappearance of all signs of MDS, including myelofibrosis, and a complete return to donor haemopoiesis. This case is the first one to suggest a graft-versus-leukaemia effect (GVL) in MDS patients. It depicts the complex relationship between GVL, graft-versus-host disease (GVHD) and graft rejection. It could also constitute a clinical illustration of the possible antileukaemic effect of CMV infection and its treatment with ganciclovir.
Scopus citations®
without self-citations
4